Dejana Braithwaite

Dejana Braithwaite,

Associate Director for Cancer Population Sciences , UF Health Cancer Center

Department: MD-SURGERY-SURGONC-BMSE
Business Phone: (352) 294-5822
Business Email: dbraithwaite@ufl.edu

About Dejana Braithwaite

Additional Positions:
Associate Director for Cancer Population Sciences
2020 – Current · UF Health Cancer Center

Accomplishments

Inductee
2017 · Royal Society of Medicine (UK)
Member, Expert Panel
2015 · National Academy of Sciences, Institute of Medicine, National Cancer Policy Forum
Mentored Research Scholar Award
2012-2017 · American Cancer Society
Career Catalyst Award
2011-2014 · Susan Komen Foundation
Junior Investigator Award
2011 · National Center of Excellence in Women’s Health, University of California, San Francisco
Junior Investigator Award
2010 · Academic Senate, University of California, San Francisco
Developmental Award
2009 · NIH Bay Area Breast Cancer Specialized Program of Research Excellence (SPORE)
Hellman Foundation Award for Early Career Faculty
2009 · University of California, San Francisco
Cancer Prevention Research Fellowship (1 awarded nationally in the United States)
2007 · Prevent Cancer Foundation/American Society for Preventive Oncology
Scholar-in-Training Award
2003 · American Association for Cancer Research, Frontiers in Cancer Prevention
Pre-doctoral Fellowship (2 awarded nationally in the United Kingdom)
2000 · Cancer Research U.K.

Teaching Profile

Courses Taught
2022-2023
PHC7918 Independent Study

Research Profile

Dr. Braithwaite’s research is focused on the intersection of cancer and aging, with the overarching goal of advancing and applying knowledge about aging to cancer population science. The overall goal is to encourage a more individualized approach to cancer screening and care among older adults.

Dr. Braithwaite has extensive experience, expertise, and leadership in large-scale multi-disciplinary NIH-funded efforts of breast and lung cancer screening, risk factors and outcomes, including the R01 Breast Cancer Surveillance Consortium (BCSC), R01 Personalized Lung Cancer Screening Network (PLuS), P50 UCSF Breast Cancer SPORE and P30 UCSF Center for Aging in Diverse Communities. As PI or investigator on several of these grants, she has developed cohorts of individuals at risk for invasive cancer and developed comprehensive databases that include pathologic, clinical, biomarker, and risk factor data, as well as follow-up for subsequent disease and death. She has performed multiple epidemiologic studies where she was able to stratify older adults at risk for or diagnosed with cancer into distinct health categories associated with substantially different life expectancies. These studies have been cited by guideline panels, such as the American Cancer Society, the US Preventive Service Taskforce and the American College of Obstetricians and Gynecologists.

Currently, she leads two large multi-site projects that integrate longitudinal cohort data with simulation modeling to determine the benefits and harms of screening for breast and lung cancers in older adults across the levels of advancing age, comorbid conditions and functional status. This work is poised to inform precision screening policy and clinical decision making among older population subgroups for whom the net benefits of screening are currently highly uncertain.

Publications

2022
A Socio-Ecological Framework for Cancer Prevention in Low and Middle-Income Countries.
Frontiers in public health. 10 [DOI] 10.3389/fpubh.2022.884678. [PMID] 35719678.
2022
Analysis of Biological Aging and Risks of All-Cause and Cardiovascular Disease-Specific Death in Cancer Survivors.
JAMA network open. 5(6) [DOI] 10.1001/jamanetworkopen.2022.18183. [PMID] 35731518.
2022
Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity.
Journal of geriatric oncology. 13(2):161-169 [DOI] 10.1016/j.jgo.2021.11.013. [PMID] 34896059.
2022
Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer’s-type neuropathology.
Brain : a journal of neurology. [DOI] 10.1093/brain/awac035. [PMID] 35094057.
2022
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
JAMA oncology. 8(3):420-444 [DOI] 10.1001/jamaoncol.2021.6987. [PMID] 34967848.
2022
Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis.
Annals of internal medicine. 175(1):11-19 [DOI] 10.7326/M20-8076. [PMID] 34807717.
2022
Expansion of Guideline-Recommended Lung Cancer Screening Eligibility: Implications for Health Equity of Joint Screening and Cessation Interventions.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 17(1):13-15 [DOI] 10.1016/j.jtho.2021.10.005. [PMID] 34930605.
2022
Frailty and risk of mortality in older cancer survivors and adults without a cancer history: Evidence from the National Health and Nutrition Examination Survey, 1999-2014.
Cancer. [DOI] 10.1002/cncr.34258. [PMID] 35608563.
2022
Mammography adherence in relation to function-related indicators in older women.
Preventive medicine. 154 [DOI] 10.1016/j.ypmed.2021.106869. [PMID] 34762965.
2022
Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study.
BMJ open. 12(6) [DOI] 10.1136/bmjopen-2022-064142. [PMID] 35732383.
2022
Procedural complications associated with invasive diagnostic procedures after lung cancer screening with low-dose computed tomography.
Lung cancer (Amsterdam, Netherlands). 165:141-144 [DOI] 10.1016/j.lungcan.2021.12.020. [PMID] 35124410.
2022
Racial Differences in Survival Among Advanced-stage Non-small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB)
Journal of Immunotherapy. 45(2):132-137 [DOI] 10.1097/CJI.0000000000000400.
2021
Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.
Cancers. 13(23) [DOI] 10.3390/cancers13236109. [PMID] 34885219.
2021
Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index.
JAMA network open. 4(8) [DOI] 10.1001/jamanetworkopen.2021.22810. [PMID] 34436608.
2021
Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019.
Annals of the American Thoracic Society. 18(11):1886-1893 [DOI] 10.1513/AnnalsATS.202010-1276OC. [PMID] 33939595.
2021
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
Clinical colorectal cancer. 20(2):137-147.e1 [DOI] 10.1016/j.clcc.2020.09.007. [PMID] 33229221.
2021
Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 30(8):1582-1590 [DOI] 10.1158/1055-9965.EPI-21-0152. [PMID] 34078641.
2021
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019 a systematic analysis for the Global Burden of Disease Study 2019
Lancet Respiratory Medicine. 9(9):1030-1049 [DOI] 10.1016/S2213-2600(21)00164-8.
2021
Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities.
Journal of immunotherapy (Hagerstown, Md. : 1997). 44(5):198-203 [DOI] 10.1097/CJI.0000000000000366. [PMID] 33758148.
2021
Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions
Journal Of Managed Care & Specialty Pharmacy. S24-S31 [DOI] 10.18553/jmcp.2021.27.9-a.s24. [PMID] 34534006.
2021
Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions.
Journal of managed care & specialty pharmacy. 27(9-a Suppl):S22-S29 [DOI] 10.18553/jmcp.2021.27.9-a.s22. [PMID] 34579542.
2021
Inflammation in Relation to Sarcopenia and Sarcopenic Obesity among Older Adults Living with Chronic Comorbidities: Results from the National Health and Nutrition Examination Survey 1999-2006.
Nutrients. 13(11) [DOI] 10.3390/nu13113957. [PMID] 34836213.
2021
Mammography use in relation to comorbidities and functional limitations among older breast cancer survivors.
Journal of cancer survivorship : research and practice. 15(1):119-126 [DOI] 10.1007/s11764-020-00917-4. [PMID] 32720225.
2021
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
Lancet. 398(10299):503-521 [DOI] 10.1016/S0140-6736(21)00984-3.
2021
Patterns of de-novo metastasis and breast cancer-specific mortality by race and molecular subtype in the SEER population-based dataset.
Breast cancer research and treatment. 186(2):509-518 [DOI] 10.1007/s10549-020-06007-4. [PMID] 33175313.
2021
Self-rated health in relation to fruit and vegetable consumption and physical activity among older cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(5):2713-2722 [DOI] 10.1007/s00520-020-05782-6. [PMID] 32979089.
2021
Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
The Lancet. Public health. [DOI] 10.1016/S2468-2667(21)00065-7. [PMID] 34051920.
2021
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
Lancet (London, England). [DOI] 10.1016/S0140-6736(21)01169-7. [PMID] 34051883.
2021
The association between cognitive impairment and breast and colorectal cancer screening utilization.
BMC cancer. 21(1) [DOI] 10.1186/s12885-021-08321-6. [PMID] 33975576.
2021
The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida.
Cancer medicine. 10(17):6048-6057 [DOI] 10.1002/cam4.4122. [PMID] 34254469.
2021
Type 2 Diabetes and association with neuropathological changes and domain specific cognitive decline
Alzheimers & Dementia. [DOI] 10.1002/alz.058476. [PMID] 34971132.
2020
Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature medicine. 26(8) [DOI] 10.1038/s41591-020-0972-7. [PMID] 32616917.
2020
Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China.
The Kaohsiung journal of medical sciences. 36(6):450-459 [DOI] 10.1002/kjm2.12175. [PMID] 31913555.
2020
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.
Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention. 26(Supp 1):i125-i153 [DOI] 10.1136/injuryprev-2019-043531. [PMID] 32839249.
2020
Five insights from the Global Burden of Disease Study 2019.
Lancet (London, England). 396(10258):1135-1159 [DOI] 10.1016/S0140-6736(20)31404-5. [PMID] 33069324.
2020
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
Lancet (London, England). 396(10258):1160-1203 [DOI] 10.1016/S0140-6736(20)30977-6. [PMID] 33069325.
2020
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Lancet (London, England). 396(10258):1223-1249 [DOI] 10.1016/S0140-6736(20)30752-2. [PMID] 33069327.
2020
Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
BMJ open. 10(1) [DOI] 10.1136/bmjopen-2019-031823. [PMID] 31911515.
2020
Is education or income associated with insufficient fruit and vegetable intake among cancer survivors? A cross-sectional analysis of 2017 BRFSS data.
BMJ open. 10(12) [DOI] 10.1136/bmjopen-2020-041285. [PMID] 33262193.
2020
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature medicine. 26(5):750-759 [DOI] 10.1038/s41591-020-0807-6. [PMID] 32313249.
2020
Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review.
JCO global oncology. 6:617-627 [DOI] 10.1200/JGO.19.00201. [PMID] 32302236.
2020
Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age.
Journal of the National Cancer Institute. 112(6):599-606 [DOI] 10.1093/jnci/djz172. [PMID] 31593591.
2020
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
The lancet. Gastroenterology & hepatology. 5(1):42-54 [DOI] 10.1016/S2468-1253(19)30328-0. [PMID] 31648970.
2019
Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study.
Journal of geriatric oncology. 10(2):265-271 [DOI] 10.1016/j.jgo.2018.07.008. [PMID] 30078713.
2019
Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.
BMC cancer. 19(1) [DOI] 10.1186/s12885-019-6144-9. [PMID] 31623592.
2019
Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.
Breast cancer research and treatment. 174(1):209-218 [DOI] 10.1007/s10549-018-5056-8. [PMID] 30465158.
2019
Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy.
Translational lung cancer research. 8(Suppl 4):S454-S459 [DOI] 10.21037/tlcr.2019.10.03. [PMID] 32038937.
2019
Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis.
Lung cancer (Amsterdam, Netherlands). 135:205-216 [DOI] 10.1016/j.lungcan.2019.06.024. [PMID] 31446996.
2019
Socioeconomic gradients in cancer incidence by race and ethnicity in California, 2008-2012: the influence of tobacco use or screening detectable cancers.
Cancer causes & control : CCC. 30(7):697-706 [DOI] 10.1007/s10552-019-01172-4. [PMID] 31065915.
2018
Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.
JAMA internal medicine. 178(4):494-501 [DOI] 10.1001/jamainternmed.2017.8642. [PMID] 29435563.
2018
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement.
American journal of respiratory and critical care medicine. 198(2):e3-e13 [DOI] 10.1164/rccm.201805-0986ST. [PMID] 30004250.
2018
Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI.
Cancers. 10(9) [DOI] 10.3390/cancers10090299. [PMID] 30200454.
2018
Screening mammography use in older women according to health status: a systematic review and meta-analysis.
Clinical interventions in aging. 13:1987-1997 [DOI] 10.2147/CIA.S171739. [PMID] 30349218.
2018
The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review.
International journal of public health. 63(7):787-797 [DOI] 10.1007/s00038-017-1060-8. [PMID] 29197969.
2017
Childhood Socioeconomic Position and Pubertal Onset in a Cohort of Multiethnic Girls: Implications for Breast Cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(12):1714-1721 [DOI] 10.1158/1055-9965.EPI-17-0496. [PMID] 28939588.
2017
Emerging Trends in Family History of Breast Cancer and Associated Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(12):1753-1760 [DOI] 10.1158/1055-9965.EPI-17-0531. [PMID] 28986348.
2017
Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(6):938-944 [DOI] 10.1158/1055-9965.EPI-16-0801. [PMID] 28096200.
2017
Lifecourse socioeconomic status and cancer-related risk factors: Analysis of the WHO study on global ageing and adult health (SAGE).
International journal of cancer. 140(4):777-787 [DOI] 10.1002/ijc.30499. [PMID] 27813060.
2017
Socio-economic status over the life course and obesity: Systematic review and meta-analysis.
PloS one. 12(5) [DOI] 10.1371/journal.pone.0177151. [PMID] 28510579.
2016
Alcohol consumption and mortality after breast cancer diagnosis: The health and functioning in women study.
Breast disease. 36(2-3):77-89 [DOI] 10.3233/BD-150202. [PMID] 27662274.
2016
Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses.
Journal of general internal medicine. 31(5):561-72 [DOI] 10.1007/s11606-015-3580-3. [PMID] 26831305.
2016
Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
International journal of cancer. 138(5):1118-28 [DOI] 10.1002/ijc.29868. [PMID] 26413860.
2016
Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO’s Study on Global Ageing and Adult Health (SAGE).
BMJ open. 6(11) [DOI] 10.1136/bmjopen-2016-012753. [PMID] 27881528.
2016
Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S.
Preventive medicine. 89:169-177 [DOI] 10.1016/j.ypmed.2016.05.034. [PMID] 27261409.
2016
Optimal breast cancer screening strategies for older women: current perspectives.
Clinical interventions in aging. 11:111-25 [DOI] 10.2147/CIA.S65304. [PMID] 26893548.
2016
Utilization of screening mammography in older women according to comorbidity and age: protocol for a systematic review.
Systematic reviews. 5(1) [PMID] 27716433.
2015
Performance of digital screening mammography among older women in the United States.
Cancer. 121(9):1379-86 [DOI] 10.1002/cncr.29214. [PMID] 25537958.
2015
Smoking and mortality after breast cancer diagnosis: the health and functioning in women study.
Cancer medicine. 4(2):315-24 [DOI] 10.1002/cam4.359. [PMID] 25511535.
2014
A multilevel model of postmenopausal breast cancer incidence.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(10):2078-92 [DOI] 10.1158/1055-9965.EPI-14-0403. [PMID] 25017248.
2014
Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(11):2613-7 [DOI] 10.1158/1055-9965.EPI-14-0848. [PMID] 25277796.
2014
Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity?
Journal of geriatric oncology. 5(3):266-75 [DOI] 10.1016/j.jgo.2014.02.003. [PMID] 24613574.
2013
Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
Journal of general internal medicine. 28(11):1454-62 [DOI] 10.1007/s11606-013-2507-0. [PMID] 23760741.
2013
Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
Cancer. 119(22):3959-67 [DOI] 10.1002/cncr.28310. [PMID] 24037812.
2013
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
JAMA internal medicine. 173(9):807-16 [DOI] 10.1001/jamainternmed.2013.307. [PMID] 23552817.
2013
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Journal of the National Cancer Institute. 105(5):334-41 [DOI] 10.1093/jnci/djs645. [PMID] 23385442.
2013
The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study.
BMJ open. 3(10) [DOI] 10.1136/bmjopen-2013-003232. [PMID] 24114369.
2013
To screen or not to screen older women for breast cancer: a conundrum.
Future oncology (London, England). 9(6):763-6 [DOI] 10.2217/fon.13.64. [PMID] 23718292.
2013
Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1638-41 [DOI] 10.1158/1055-9965.EPI-13-0655. [PMID] 23845714.
2012
Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(9):1606-10 [DOI] 10.1158/1055-9965.EPI-12-0848. [PMID] 22850804.
2012
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(7):1115-25 [DOI] 10.1158/1055-9965.EPI-11-1228. [PMID] 22573797.
2012
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review.
Breast cancer research and treatment. 136(2):521-33 [DOI] 10.1007/s10549-012-2276-1. [PMID] 23053660.
2011
The relative importance of predictors of body mass index change, overweight and obesity in adolescent girls.
International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity. 6(2-2):e233-42 [DOI] 10.3109/17477166.2010.545410. [PMID] 21244233.
2010
Long-term prognostic role of functional limitations among women with breast cancer.
Journal of the National Cancer Institute. 102(19):1468-77 [DOI] 10.1093/jnci/djq344. [PMID] 20861456.
2010
Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(7):1665-7 [DOI] 10.1158/1055-9965.EPI-10-0523. [PMID] 20615883.
2010
Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
Journal of genetic counseling. 19(5):447-62 [DOI] 10.1007/s10897-010-9303-3. [PMID] 20490636.
2009
Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients.
International journal of cancer. 124(5):1213-9 [DOI] 10.1002/ijc.24054. [PMID] 19058216.
2009
Socioeconomic status in relation to early menarche among black and white girls.
Cancer causes & control : CCC. 20(5):713-20 [DOI] 10.1007/s10552-008-9284-9. [PMID] 19107561.
2005
Development of a risk assessment tool for women with a family history of breast cancer.
Cancer detection and prevention. 29(5):433-9 [PMID] 16055276.

Grants

Jun 2022 ACTIVE
University of Florida Claude D. Pepper Older Americans Independence Center
Role: Other
Funding: NATL INST OF HLTH NIA
Sep 2021 ACTIVE
Comorbidity and Screening Outcomes Among Older Women Undergoing Mammography
Role: Principal Investigator
Funding: NATL INST OF HLTH NCI
Jun 2021 ACTIVE
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
Role: Principal Investigator
Funding: NATL INST OF HLTH NCI
Jan 2020 ACTIVE
The benefits and harms of lung cancer screening in Florida
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI

Education

Fellow, Epidemiology and Public Health
2017-2021 · Royal Society of Medicine
Cancer Prevention Fellow
2006-2008 · American Society of Preventive Oncology/Prevent Cancer Foundation
Postdoctoral Fellow, Center for Health and Community
2006-2007 · University of California, San Francisco
Postdoctoral Fellow in Cancer Epidemiology
2004-2007 · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Postdoctoral Fellow in Health Services Research, Institute for Health Policy Studies
2004-2006 · University of California, San Francisco
Fellow in Health Outcomes Research
2000-2004 · Institute of Public Health, University of Cambridge, England and Cancer Research
Ph.D., Epidemiology
2000-2004 · University of Cambridge, Institute of Public Health, Faculty of Clinical Medicine, England
M.Sc. (high honors), Public Health
1998-1999 · University College London/Kings College, England
B.Sc. (high honors), Psychology and Psychobiology
1995-1998 · London Guildhall University, England

Contact Details

Phones:
Business:
(352) 294-5822
Emails:
Administrative Specialist II:
Addresses:
Business Mailing:
PO BOX 103633
GAINESVILLE DC 32610